November 13, 2026 · Pediatric nephrology (Berlin, Germany) · DOI: 10.1007/s00467-026-07611-0

Caffeine for prevention of acute kidney injury in neonates with perinatal asphyxia: a randomized placebo-controlled trial.

Listen to this summary

This double-blind randomized controlled trial asked whether a single intravenous dose of caffeine citrate (20 mg/kg) given within 2 hours of birth could prevent acute kidney injury in term and late-preterm neonates (≥35 weeks) with perinatal asphyxia. In 78 neonates, AKI occurred in 28.2% of the caffeine group and 35.9% of the normal saline group, a difference that was not statistically significant (p = 0.467), and there were also no significant differences in AKI severity, kidney and cerebral markers, HIE incidence, or neurological scores at discharge. The authors concluded that a single caffeine dose at birth did not reduce AKI or HIE, and they call for further research on dosing, frequency, and use in infants receiving therapeutic hypothermia.

Pavanakumar Karigoudar, Mayank Priyadarshi, Kiran Meena, Poonam Singh, Suman Chaurasia, Sriparna Basu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play